(Q77764406)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9880091%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9880091%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

main subject

peripheral neuropathy

1 reference

G J Moyle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9880091%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Sadler

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9880091%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9880091%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9880091%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9880091%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9880091%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

481-494

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9880091%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00002018-199819060-00005

8 December 2019

exact match

0 references

cites work

Exacerbation of dideoxycytidine-induced neuropathy with dideoxyinosine

1 reference

12 December 2020

Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group

1 reference

12 December 2020

The role of didanosine in the management of HIV-1 infection.

1 reference

12 December 2020

A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

12 December 2020

Axonal atrophy in the painful peripheral neuropathy in AIDS.

1 reference

12 December 2020

Exacerbation of peripheral neuropathy by lamivudine

1 reference

12 December 2020

Subclinical peripheral nerve involvement in AIDS: an electrophysiological and pathological study

1 reference

12 December 2020

The Alpha trial: European/Australian randomized double-blind trial of two doses of didanosine in zidovudine-intolerant patients with symptomatic HIV disease. Alpha International Coordinating Committee

1 reference

12 December 2020

Adenine arabinoside monophosphate (vidarabine phosphate) in combination with human leukocyte interferon in the treatment of chronic hepatitis B. A randomized, double-blinded, placebo-controlled trial

1 reference

12 December 2020

Combination therapy with zidovudine and dideoxycytidine in patients with advanced human immunodeficiency virus infection. A phase I/II study

1 reference

12 December 2020

Nerve growth factor binding in aged rat central nervous system: effect of acetyl-L-carnitine

1 reference

12 December 2020

Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy

1 reference

12 December 2020

Cytokine expression in the brain during the acquired immunodeficiency syndrome

1 reference

12 December 2020

Cytomegalovirus and the peripheral nervous system in AIDS

1 reference

12 December 2020

The use and toxicity of didanosine (ddI) in HIV antibody-positive individuals intolerant to zidovudine (AZT)

1 reference

12 December 2020

Acoustic neuropathy associated with zalcitabine-induced peripheral neuropathy.

1 reference

12 December 2020

British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals. BHIVA Guidelines Co-ordinating Committee

1 reference

12 December 2020

Neuroprotective activity of acetyl-L-carnitine: studies in vitro.

1 reference

12 December 2020

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

12 December 2020

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

1 reference

12 December 2020

A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group

1 reference

12 December 2020

Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex

1 reference

12 December 2020

Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity

1 reference

12 December 2020

Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.

1 reference

12 December 2020

Safety and tolerability of zalcitabine (ddC) in patients with AIDS or advanced AIDS-related complex in the European expanded access programme.

1 reference

12 December 2020

Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey

1 reference

12 December 2020

The role of carnitine in intracellular metabolism

1 reference

12 December 2020

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

1 reference

12 December 2020

2',3'-didehydro-3'-deoxythymidine (d4T) in patients with AIDS or AIDS-related complex: a phase I trial

1 reference

12 December 2020

Long-term acetyl-L-carnitine treatment in Alzheimer's disease

1 reference

12 December 2020

L-acetylcarnitine as a new therapeutic approach for peripheral neuropathies with pain

1 reference

12 December 2020

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

1 reference

12 December 2020

Peripheral neuropathy in the acquired immunodeficiency syndrome

1 reference

12 December 2020

Phase I studies of 2',3'-dideoxycytidine in severe human immunodeficiency virus infection as a single agent and alternating with zidovudine (AZT).

1 reference

12 December 2020

The didanosine Expanded Access Program: safety analysis

1 reference

12 December 2020

2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients

1 reference

12 December 2020

Biologic effects and safety of stavudine: overview of phase I and II clinical trials

1 reference

12 December 2020

Ototoxicity associated with dideoxycytidine

1 reference

12 December 2020

Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter. Investigators for the Terry Beirn Community Programs for Clinica

1 reference

12 December 2020

2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. A phase I trial

1 reference

12 December 2020

Safety and activity of zalcitabine and zidovudine combination in HIV-positive people with CD4 cell counts < or = 300 cells/mm3. The Roche M50002 Study Group.

1 reference

12 December 2020

Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection

1 reference

12 December 2020

The pc12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV-1 dideoxynucleoside analogs

1 reference

12 December 2020

Phase I study of 2′-3′-dideoxyinosine administered orally twice daily to patients with AIDS or AIDS-related complex and hematologic intolerance to zidovudine

1 reference

12 December 2020

Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection.

1 reference

12 December 2020

1 reference

12 December 2020

Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.

1 reference

12 December 2020

Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Delta Coordinating Committee

1 reference

12 December 2020

The spectrum of polyneuropathies in patients infected with HIV.

1 reference

12 December 2020

Extended follow-up of peripheral neuropathy in patients with AIDS and AIDS-related complex treated with dideoxyinosine

1 reference

12 December 2020

Nature and incidence of peripheral nerve syndromes in HIV infection

1 reference

12 December 2020

Mitochondrial toxicity of antiviral drugs

1 reference

12 December 2020

Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.

1 reference

12 December 2020

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

1 reference

12 December 2020